62 results
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
9 Feb 24
Departure of Directors or Certain Officers
5:08pm
or comply with Section 409A.
LIMITATION ON RIGHTS.
Retention Rights. Neither the Plan nor any Award granted under the Plan shall be deemed to give
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
Providers to focus on critical long-range corporate objectives, (b) encouraging the attraction and retention of Service Providers with exceptional
8-K
EX-2.1
qoot x5at5
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-10.1
jro425dzflh5klkl0q
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-10.2
zda660v fk6p9227qo
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
S-8
EX-99.6
7m8pay 5j12bh
29 Oct 21
Registration of securities for employees
5:18pm
S-8
EX-99.5
yxqz94ofi1ni5qxmp4
29 Oct 21
Registration of securities for employees
5:18pm
8-K
EX-10.4
uexucl6yq toxx
14 Apr 21
Alimera Sciences receives $20 million
9:12am